Linhui Peng, Yajin Chen, Tao Chen, Jie Wang, Xiao Hu, Yong Li, Jiahong Zhu, Xiaoqiang Fang, Jiahui Liu. "CAREFOL: A phase 3, randomized, open-label, multicenter trial of camrelizumab and rivoceranib with or without intravenous FOLFOX chemotherapy as first-line treatment for unresectable hepatocellular carcinoma.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps4257